Speech Language Pathologist (1099 Contract)

About Synapticure Synapticure is the largest, most comprehensive specialty care and life sciences company in the country for those living with neurodegenerative diseases. Founded by patients and caregivers living with these diseases, we are redefining the care and the research paradigm for conditions like Alzheimer's, Parkinson's, and ALS in all 50 states. Our business is powered by two connected engines.

The CARES Engine (Clinical Operations) A scalable, 50-state virtualized clinical network providing timely access to expert neurologists and cutting edge treatments with wraparound care coordination and behavioral health support. Our team creates personalized care plans focused on education and empowerment, connecting patients with a multidisciplinary team of subspecialty neurologists, geriatricians, psychologists, and care coordinators who collaborate to deliver comprehensive care.

The CURES Engine (Research & Innovation) Leveraging our deeply engaged, well characterized national patient cohort, CURES partners with life science, pharma, biotech, and medical device companies to accelerate the development of neurodegenerative treatments, spanning discovery stage lab services, clinical trial services, and real world evidence data and analytics. Partnering with providers, health plans, and life sciences companies, including CMS' GUIDE dementia care model, Synapticure is dedicated to transforming the lives of millions of individuals and their families living with neurodegenerative diseases.

About the Role This role is a 1099 contract role, targeting 10-20 hours per week. We are seeking a compassionate, collaborative Speech-Language Pathologist (SLP) to provide assessment, intervention, and longitudinal care for adults with progressive neurodegenerative conditions across a fully remote, telehealth-based model. This role focuses primarily on direct patient care, including evaluation, evidence-based treatment, caregiver education, and interdisciplinary collaboration.

Working closely with senior clinical team members, the SLP will manage a varied caseload of patients with Parkinson’s disease, ALS, Huntington’s disease, FTD/PPA variants, and related neurologic conditions, adapting clinical care to disease progression and patient goals. The Day-to-Day Assessment & Diagnosis Conduct virtual speech, language, cognitive-communication, motor speech, voice, and dysphagia risk evaluations using standardized assessments and functional task analysis adapted for telehealth.

Interpret findings to establish diagnostic impressions, identify functional goals, and formulate measurable, patient-centered treatment plans. Recognize when additional assessment, referral, or consultation with the Senior SLP is warranted, including when a patient’s needs extend beyond the scope of telehealth services. Treatment & Intervention Deliver stage-appropriate, evidence-based interventions for progressive neurologic conditions, including: Cognitive-communication therapy targeting functional daily tasks, memory, and executive function.

Motor speech therapy and compensatory communication techniques. Voice banking, message banking, and early communication-preservation planning. Augmentative and Alternative Communication (AAC) evaluation, trial support, and caregiver training. Telehealth-appropriate dysphagia screening, education, compensatory strategy training, and referral for instrumental assessment when indicated. Adapt intervention plans as clinical needs, functional priorities, and disease stages shift over time.

Educate caregivers and family members on communication strategies, cueing techniques, and environmental modifications to ensure skill carryover. Collaboration & Team Integration Partner with neurologists, care coordinators, behavioral health providers, and senior SLPs to align on care priorities and manage complex cases. Participate in interdisciplinary case conferences, clinical consultation, and case review as appropriate.

Documentation